Abstract:
Efforts have been intensified to search for more effective antimalarial agents because of the observed failure of some artemisinin-
based combination therapy (ACT) treatments of malaria in Ghana. Xylopic acid, a pure compound isolated from the fruits of the
Xylopia aethiopica, was investigated to establish its attributable prophylactic, curative antimalarial, and antipyretic properties. The
antimalarial properties were determined by employing xylopic acid (10–100 mg/kg) in ICR mice infected with Plasmodium berghei.
Xylopic acid exerted significant (𝑃 < 0.05) effects on P. berghei infection similar to artemether/lumefantrine, the standard drug.
Furthermore, it significantly (𝑃 < 0.05) reduced the lipopolysaccharide- (LPS-) induced fever in Sprague-Dawley rats similar to
prednisolone. Xylopic acid therefore possesses prophylactic and curative antimalarial as well as antipyretic properties which makes
it an ideal antimalarial agent.
